Yulun Wang, founder and CEO, InTouch Health, Inc.

Yulun Wang, Ph.D., is the founder and CEO of InTouch Health, Inc., a bio-medical start-up based in Santa Barbara, California.

InTouch Health produces RP-6 robots for use in hospital settings. These units allow doctors to leverage their expertise through "remote presence" at the bedside of their patients in RP-6-equipped hospitals. The RP-6 unit allows doctors to interact remotely in real time with their patients, and to simultaneously examine their digitized medical records from their offices or homes, while avoiding the expensive, delay, inconvenience, and annoyances of traveling from home to hospital or from hospital to hospital during a busy day.

Four of InTouch Health's RP-6 remote presence robots are now operating at the Shawnee Mission Medical Center in suburban Kansas City, Kansas. You can read about their deployment there in a July 27, 2005, press release from the medical center entitled "Midwest Hospital Leads Nation's Use of Revolutionary Robot to Increase Patient-Physician Communication."

Etopia Media Medical News Network spoke today with Yulun Wang about how those robots were introduced at Shawnee Mission Medical Center, the uses to which they are now being put, the warm reception they've received there from physicians, nurses, patients, and hospital administrators, how they synergize with the increasing computerization of medical records, and how they are improving patient access to physician expertise and saving money for the hospital that has bought and is using them.

You can listen to that conversation with Yulun Wang, founder and CEO of InTouch Health, makers of the RP-6 remote presence medical robot, in its entirety, by clicking here.

You can watch and listen to an earlier, April 7, 2005, remotely-recorded video interview of Yulun Wang talking about the RP-6 robot and how it is being used in medical practice today by clicking here.

To read about an on-going trial of the RP-6 robot at the intensive care unit at the UCLA Medical Center, click here. To go directly to a remotely-recorded video interview with Dr. Neil Martin, project director for that trial, click here.